doi:10.1016/j.virs.2022.04.004

[1]
Suyan Tian, Xuetong Zhu, Xuejuan Sun, Jinmei Wang, Qi Zhou, Chi Wang, Li Chen, Shanji Li, Jiancheng Xu, 2020: A Prognostic Model to Predict Recovery of COVID-19 Patients Based on Longitudinal Laboratory Findings, Virologica Sinica, 35, 811-819. doi: 10.1007/s12250-020-00317-z
[2]
Jun-Bo Zhou, Wen-Hua Kong, Sheng Wang, Yi-Bing Long, Lian-Hua Dong, Zhen-Yu He, Man-Qing Liu, 2021: Detection of SARS-CoV-2 RNA in Medical Wastewater in Wuhan During the COVID-19 Outbreak, Virologica Sinica, 36, 1077-1079. doi: 10.1007/s12250-021-00373-z
[3]
Ruhan A, Huijuan Wang, Wenling Wang, Wenjie Tan, 2020: Summary of the Detection Kits for SARS-CoV-2 Approved by the National Medical Products Administration of China and Their Application for Diagnosis of COVID-19, Virologica Sinica, 35, 699-712. doi: 10.1007/s12250-020-00331-1
[4]
Junsen Chen, Rui Huang, Yiwen Nie, Xinyue Wen, Ying Wu, 2020: Human Monoclonal Antibodies: On the Menu of Targeted Therapeutics Against COVID-19, Virologica Sinica, 35, 713-724. doi: 10.1007/s12250-020-00327-x
[5]
Xiaojun Wu, Tong Wang, Yilu Zhou, Xiaofan Liu, Hong Zhou, Yang Lu, Weijun Tan, Mingli Yuan, Xuhong Ding, Jinjing Zou, Ruiyun Li, Hailing Liu, Rob M. Ewing, Yi Hu, Hanxiang Nie, Yihua Wang, 2020: Different Laboratory Abnormalities in COVID-19 Patients with Hypertension or Diabetes, Virologica Sinica, 35, 853-856. doi: 10.1007/s12250-020-00296-1
[6]
Zhihua Bai, Yue Gong, Xiaodong Tian, Ying Cao, Wenjun Liu, Jing Li, 2020: The Rapid Assessment and Early Warning Models for COVID-19, Virologica Sinica, 35, 272-279. doi: 10.1007/s12250-020-00219-0
[7]
Xiaohua Chen, Juan Zhou, Chen Chen, Baidong Hou, Ashaq Ali, Feng Li, Zhaolin Hua, Yingtao Wu, Qin Yang, Min Chen, Rong Zhang, Qianchuan Huang, Jinya Ding, Xian-En Zhang, Dong Men, 2021: Consecutive Monitoring of Interleukin-6 Is Needed for COVID-19 Patients, Virologica Sinica, 36, 1093-1096. doi: 10.1007/s12250-021-00425-4
[8]
Wenyi Guan, Wendong Lan, Jing Zhang, Shan Zhao, Junxian Ou, Xiaowei Wu, Yuqian Yan, Jianguo Wu, Qiwei Zhang, 2020: COVID-19: Antiviral Agents, Antibody Development and Traditional Chinese Medicine, Virologica Sinica, 35, 685-698. doi: 10.1007/s12250-020-00297-0
[9]
Junwei Li, Mingyue Song, Deyin Guo, Yongxiang Yi, 2021: Safety and Considerations of the COVID-19 Vaccine Massive Deployment, Virologica Sinica, 36, 1097-1103. doi: 10.1007/s12250-021-00408-5
[10]
Carlos M. Chiesa-Estomba, Jerome R. Lechien, Maria R. Barillari, Sven Saussez, 2020: Patterns of Gustatory Recovery in Patients Affected by the COVID-19 Outbreak, Virologica Sinica, 35, 833-837. doi: 10.1007/s12250-020-00272-9
[11]
Raimonds Rescenko, Raitis Peculis, Monta Briviba, Laura Ansone, Anna Terentjeva, Helena Daiga Litvina, Liga Birzniece, Kaspars Megnis, Oksana Kolesova, Baiba Rozentale, Ludmila Viksna, Vita Rovite, Janis Klovins, 2021: Replication of LZTFL1 Gene Region as a Susceptibility Locus for COVID-19 in Latvian Population, Virologica Sinica, 36, 1241-1244. doi: 10.1007/s12250-021-00448-x
[12]
Franck J. D. Mennechet, Guy R. Takoudjou Dzomo, 2020: Coping with COVID-19 in Sub-Saharan Africa: What Might the Future Hold?, Virologica Sinica, 35, 875-884. doi: 10.1007/s12250-020-00279-2
[13]
Raimonds Rescenko, Raitis Peculis, Monta Briviba, Laura Ansone, Anna Terentjeva, Helena Daiga Litvina, Liga Birzniece, Kaspars Megnis, Oksana Kolesova, Baiba Rozentale, Ludmila Viksna, Vita Rovite, Janis Klovins, 2021: Correction to: Replication of LZTFL1 Gene Region as a Susceptibility Locus for COVID-19 in Latvian Population, Virologica Sinica, 36, 1692-1692. doi: 10.1007/s12250-021-00464-x
[14]
Wen-Hua Kong, Rong Zhao, Jun-Bo Zhou, Fang Wang, De-Guang Kong, Jian-Bin Sun, Qiong-Fang Ruan, Man-Qing Liu, 2020: Serologic Response to SARS-CoV-2 in COVID-19 Patients with Different Severity, Virologica Sinica, 35, 752-757. doi: 10.1007/s12250-020-00270-x
[15]
Shengxue Luo, Panli Zhang, Peng Zou, Cong Wang, Bochao Liu, Cuiling Wu, Tingting Li, Ling Zhang, Yuming Zhang, Chengyao Li, 2021: A Self-Biomineralized Novel Adenovirus Vectored COVID-19 Vaccine for Boosting Immunization of Mice, Virologica Sinica, 36, 1113-1123. doi: 10.1007/s12250-021-00434-3
[16]
Xiaohui Zou, Shengrui Mu, Yeming Wang, Li Guo, Lili Ren, Xiaoyan Deng, Haibo Li, Jiankang Zhao, Yulin Zhang, Hui Li, Binghuai Lu, Chaolin Huang, Bin Cao, 2022: Characterization of two SARS-CoV-2 subgenomic RNA dynamics in severe COVID-19 patients, Virologica Sinica, 37, 30-37. doi: 10.1016/j.virs.2022.01.008
[17]
Bali Zhao, Maohua Zhong, Qingyu Yang, Ke Hong, Jianbo Xia, Xia Li, Ying Liu, Yao-Qing Chen, Jingyi Yang, Chaolin Huang, Huimin Yan, 2021: Alterations in Phenotypes and Responses of T Cells Within 6 Months of Recovery from COVID-19: A Cohort Study, Virologica Sinica, 36, 859-868. doi: 10.1007/s12250-021-00348-0
[18]
Huaqing Shu, Shuzhen Wang, Shunan Ruan, Yaxin Wang, Jiancheng Zhang, Yin Yuan, Hong Liu, Yongran Wu, Ruiting Li, Shangwen Pan, Yaqi Ouyang, Shiying Yuan, Peng Zhou, You Shang, 2020: Correction to: Dynamic Changes of Antibodies to SARS-CoV-2 in COVID-19 Patients at Early Stage of Outbreak, Virologica Sinica, 35, 887-887. doi: 10.1007/s12250-020-00318-y
[19]
Hongming Huang, Jia Liu, 2023: Role of inactivated SARS-CoV-2 vaccine induced T cell responses in ameliorating COVID-19 severity, Virologica Sinica, 38, 324-326. doi: 10.1016/j.virs.2023.02.003
[20]
Jun Chen, Jing Yang, Fangfang Chang, Yabin Hu, Qian Wu, Shishan Teng, Yongchen Liu, Jian Zhang, Rongzhang He, Bo Liu, Xingyu Zheng, Ze Liu, Yanxi Peng, Zhenhua Xie, Yuanfang Zhang, Rui Lu, Dong Pan, You Wang, Liting Peng, Wenpei Liu, Yi-Ping Li, Xiaowang Qu, 2023: Identification of broad neutralizing antibodies against Omicron subvariants from COVID-19 convalescents and vaccine recipients, Virologica Sinica, 38, 313-316. doi: 10.1016/j.virs.2023.01.005